<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2020-10-12</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-2314</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>POINT OF VIEW</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТОЧКА ЗРЕНИЯ</subject></subj-group></article-categories><title-group><article-title>Possible Approaches to Primary Prevention of Cardiovascular Diseases</article-title><trans-title-group xml:lang="ru"><trans-title>Возможные подходы к первичной профилактике сердечно-сосудистых заболеваний</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларина</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Larina</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ларина Вера Николаевна – доктор медицинских наук, профессор, заведующий кафедрой поликлинической терапии</p><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Vera N. Larina – MD, PhD, Professor, Head of Chair of Outpatient Therapy</p><p>Ostrovitianova ul. 1, Moscow, 117997 </p></bio><email xlink:type="simple">larinav@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мкртычев</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mkrtychev</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мкртычев Давид Самвелович – студент</p><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>David S. Mkrtychev – Student</p><p>Ostrovitianova ul. 1, Moscow, 117997 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецова Вероника Андреевна – студент</p><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Veronika A. Kuznetsova – Student</p><p>Ostrovitianova ul. 1, Moscow, 117997 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тяжельников</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyazhelnikov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тяжельников Андрей Александрович – главный врач</p><p>117042, Москва, ул. Южнобутовская, 87 </p></bio><bio xml:lang="en"><p>Andrey A. Tyazhelnikov – MD, Chief Medical Officer</p><p>Uzhnobutovskaya ul. 87, Moscow, 117042 </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Консультативно-диагностическая поликлиника №121</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Consultative and Diagnostic Polyclinic №121</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>04</day><month>11</month><year>2020</year></pub-date><volume>16</volume><issue>5</issue><fpage>831</fpage><lpage>841</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Larina V.N., Mkrtychev D.S., Kuznetsova V.A., Tyazhelnikov A.A., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ларина В.Н., Мкртычев Д.С., Кузнецова В.А., Тяжельников А.А.</copyright-holder><copyright-holder xml:lang="en">Larina V.N., Mkrtychev D.S., Kuznetsova V.A., Tyazhelnikov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/2314">https://www.rpcardio.online/jour/article/view/2314</self-uri><abstract><p>In recent years there is a positive trend in the development of preventive medicine, in particular, primary prevention of diseases. However, in most cases, patients seek help from a doctor after the manifestation of the disease, and therefore, early identification of risk factors (RF) remains relevant. Conduction of a large number of studies that are aimed at studying modifiable RF associated with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop recommendations “Life's Simple 7”, which makes it possible to structure methods of primary prevention of CVD and minimize the risk of their development. In 2019, experts from the American College of Cardiology presented a simplified version of these recommendations, to improve approaches to primary prevention and their effectiveness not only for doctors but also for patients. Thus, by involving the patient in the decision-making process about follow-up treatment, doctors can achieve a high level of compliance, which is essential for improving the prognosis. The “ABCDE” recommendations, in name of which are reflected the first letters of the leading CVD RF, include such paragraphs as RF assessment, the use of antiaggregating therapy, correction of blood pressure, cholesterol levels, smoking elimination, correction of high glucose levels and diabetes treatment, weight loss, assessment of social and economic factors affecting the morbidity in a particular patient. Despite the undoubted benefit of the “ABCDE” recommendations, some problems of primary prevention currently cannot be solved: the inability to accurately assess social and economic RF; the imperfection of the used CVD risk scales. The updated version of the recommendations allows not only to assess the existing RF of the patient, but also to effectively correct them. In addition, the patient himself can read the recommendations, which improves understanding of the primary prevention importance.</p></abstract><trans-abstract xml:lang="ru"><p>В последние годы в мире наблюдается положительная тенденция в развитии профилактической медицины, в частности, первичной профилактики заболеваний. Однако в большинстве случаев пациенты обращаются за помощью к врачу уже после манифестации заболевания, в связи с чем раннее выявление факторов риска (ФР) сохраняет свою актуальность. Проведение большого количества исследований, направленных на изучение модифицируемых ФР, ассоциируемых с развитием сердечно-сосудистых заболеваний (ССЗ), дало возможность экспертам Американской Ассоциации сердца разработать рекомендации «Life’s Simple 7», позволяющие структурировать методы первичной профилактики ССЗ и максимально снизить риск их развития. В 2019 г. эксперты American College of Cardiology представили упрощенную версию данных рекомендаций с целью улучшения подходов к первичной профилактике и их эффективности не только для врачей, но и для пациентов. Таким образом, вовлекая пациента в процесс принятия решений о последующем лечении, врачи способны достичь высокого уровня приверженности, что имеет крайне важное значение для улучшения прогноза. В рекомендациях “ABCDE“, название которых отражает первые буквы ведущих ФР ССЗ, входят такие пункты, как оценка ФР, применение дезагрегантной терапии, коррекция артериального давления, уровня холестерина и глюкозы, в том числе, при сахарном диабете, исключение курения, снижение массы тела, оценка социальных и экономических ФР, влияющих на заболеваемость у конкретного пациента. Несмотря на несомненную пользу рекомендаций “ABCDE“, некоторые проблемы первичной профилактики в настоящее время решить не удается: невозможность точной оценки социальных и экономических ФР; несовершенность используемых шкал риска развития ССЗ и др. Обновленная версия рекомендаций позволяет не только оценить имеющиеся ФР у пациента, но и эффективно их корректировать. Кроме того, и сам пациент имеет возможность ознакомиться с рекомендациями, что улучшает понимание важности первичной профилактики.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первичная профилактика</kwd><kwd>хронические неинфекционные заболевания</kwd><kwd>сердечно-сосудистый риск</kwd><kwd>лечение</kwd><kwd>диета</kwd><kwd>образ жизни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary prevention</kwd><kwd>chronic non-communicable diseases</kwd><kwd>cardiovascular risk</kwd><kwd>treatment</kwd><kwd>diet</kwd><kwd>lifestyle</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Концевая А.В., Драпкина О.М. Экономика профилактики неинфекционных заболеваний. Профилактическая Медицина. 2018;21(2):4-10. DOI:10.17116/profmed20182124-10.</mixed-citation><mixed-citation xml:lang="en">Kontsevaya A.V., Drapkina O.M. Economics of the prevention of chronic non-communicable diseases. Russian Journal of Preventive Medicine and Public Health. Profilakticheskaya Meditsina. 2018;21(2):4- 10 (In Russ.) DOI:10.17116/profmed20182124-10.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Katharina L., von Schacky C., McKenzie A.L., et al. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2020 Mar;27(4):394-406. DOI:10.1177/2047487319869400.</mixed-citation><mixed-citation xml:lang="en">Katharina L., von Schacky C., McKenzie A.L., et al. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur J Prev Cardiol. 2020 Mar;27(4):394-406. DOI:10.1177/2047487319869400.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О.М., Дроздова Л.Ю., Калинина А.М., и др. Организация проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения. Методические рекомендации по практической реализации приказа Минздрава России от 13 марта 2019 г. N 124н «Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения». М.: НМИЦТПМ; 2019.</mixed-citation><mixed-citation xml:lang="en">Drapkina O.M., Drozdova L.Yu., Kalinina A.M., et al. Organization of preventive medical examination and medical examination of certain groups of the adult population. Guidelines for the practical implementation of the order of the Ministry of Health of Russia dated March 13, 2019 N 124н “On approval of the procedure for conducting preventive medical examination and medical examination of certain groups of the adult population”. Moscow: NMITsTPM; 2019 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина А.М., Кушунина Д.В., Горный Б.Э. Повышение качества диспансеризации взрослого населения как важный инструмент профилактики сердечно-сосудистых заболеваний в первичном звене здравоохранения. Профилактическая Медицина. 2018;21(5):22-7. DOI:10.17116/profmed20182105122.</mixed-citation><mixed-citation xml:lang="en">Kalinina A.M., Kushunina D.V., Gornyj B.E. The tasks of improving the quality of medical examination of the adult population as an important tool to prevent cardiovascular diseases in primary health care. Preventive Medicine. 2018;21(5):227 (In Russ.) DOI:10.17116/profmed20182105122.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина А.М., Кушунина Д.В., Горный Б.Э., и др. Потенциал профилактики сердечно-сосудистых заболеваний по результатам диспансеризации взрослого населения. Кардиоваскулярная Терапия и Профилактика. 2019;18(4):69-76. DOI:10.15829/1728-8800-2019-4-69-76.</mixed-citation><mixed-citation xml:lang="en">Kalinina A.M., Kushunina D.V., Gornyi B.E., et al. The potential of cardiovascular diseases’ prevention according to the results of dispensary examinations of the adult population. Cardiovascular Therapy and Prevention. 2019;18(4):69-76 (In Russ.) DOI:10.15829/1728-8800-2019-4-69-76.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli M.F., Hoes A.W., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation><mixed-citation xml:lang="en">Piepoli M.F., Hoes A.W., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Уразалина С. Ж., Семенова А. Е., Сергиенко И. В., и др. Субклинический атеросклероз как фактор риска сердечно-сосудистых осложнений. Кардиоваскулярная Терапия и Профилактика. 2012;11(3):82-6.</mixed-citation><mixed-citation xml:lang="en">Urazalina S.J., Semenova A.E., Sergienko I.V., et al. Subclinical atherosclerosis as cardiovascular events risk factor. Cardiovascular Therapy and Prevention. 2012;11(3):82-6 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F., Baigent C., Catapano A.L., et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205. DOI:10.1016/j.atherosclerosis.2019.08.014.</mixed-citation><mixed-citation xml:lang="en">Mach F., Baigent C., Catapano A.L., et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205. DOI:10.1016/j.atherosclerosis.2019.08.014.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Screening for cardiovascular risk in asymptomatic patients J Am Coll Cardiol. 2010;55(12):1169-77. DOI:10.1016/j.jacc.2009.09.066.</mixed-citation><mixed-citation xml:lang="en">Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Screening for cardiovascular risk in asymptomatic patients J Am Coll Cardiol. 2010;55(12):1169-77. DOI:10.1016/j.jacc.2009.09.066.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина А.М. Первичная многофакторная профилактика ишемической болезни сердца среди мужчин среднего возраста и ее эффективность (10-летнее наблюдение). Рациональная Фармакотерапия в Кардиологии. 2014;10(1):6-17. DOI:10.20996/1819-6446-2014-10-1-6-17.</mixed-citation><mixed-citation xml:lang="en">Kalinina A.M. Multifactor primary prevention of ischemic heart disease in middle-aged men and its efficacy (10-year follow-up). Rational Pharmacotherapy in Cardiology. 2014;10(1):6-17 (In Russ.) DOI:10.20996/1819-6446-2014-10-1-6-17.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. DOI:10.1161/CIR.0000000000000678.</mixed-citation><mixed-citation xml:lang="en">Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. DOI:10.1161/CIR.0000000000000678.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Паспорт приоритетного проекта «Формирование здорового образа жизни» [цитировано 12.01.2019. Доступно на: http://base.garant.ru/71748614/.</mixed-citation><mixed-citation xml:lang="en">Passport of the priority project “Formation of a healthy lifestyle” [cited by Jan 12, 2019]. Available from: http://base.garant.ru/71748614/ (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Баланова Ю.А., Деев А.Д., и др. Интегральная оценка приверженности здоровому образу жизни как способ мониторинга эффективности профилактических мер. Профилактическая Медицина. 2018;21(4):65-72. DOI:10.17116/profmed201821465.</mixed-citation><mixed-citation xml:lang="en">Shalnova S.A., Balanova Yu.A., Deev A.D., et al. Integral assessment of adherence to a healthy lifestyle as a way to monitor the effectiveness of preventive measures. Preventative Medicine. 2018;21(4):65- 72. (In Russ.) DOI:10.17116/profmed201821465.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Капустина А.В., Деев А.Д., Баланова Ю.А. Факторы, ассоциированные с основными причинами смерти в России. Данные многолетнего проспективного исследования 1977-2001 гг. Рациональная Фармакотерапия в Кардиологии. 2019;15(1):4- 16. DOI:10.20996/1819-6446-2019-15-1-4-16.</mixed-citation><mixed-citation xml:lang="en">Shalnova S.A., Kapustina A.V., Deev A.D., Balanova YA. Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001. Rational Pharmacotherapy in Cardiology. 2019;15(1):4-16 (In Russ.) DOI:10.20996/1819-6446-2019-15-1-4-16.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Долгалев И. В., Бразовская Н. Г., Иванова А. Ю., и др. Влияние артериальной гипертензии, курения и их сочетания на смертность (по результатам 27-летнего когортного проспективного исследования неорганизованной популяции г. Томска). Российский Кардиологический Журнал. 2019;24(1):32-7. DOI:10.15829/1560-4071-2019-1-32-37.</mixed-citation><mixed-citation xml:lang="en">Dolgalev I.V., Brazovskaya N.G., Ivanova A.Y., et al. Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk). Russian Journal of Cardiology. 2019;(1):32-7 (In Russ.) DOI:10.15829/1560-4071-2019-1-32-37.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177-e232. DOI:10.1016/j.jacc.2019.03.010.</mixed-citation><mixed-citation xml:lang="en">Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177-e232. DOI:10.1016/j.jacc.2019.03.010.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Погосова Н.В. Кардиоваскулярная профилактика 2017. Национальные рекомендации. Российский Кардиологический Журнал. 2018;23(6):7-122. DOI:10.15829/1560-4071-2018-6-7-122.</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A., Pogosova N.V. Cardiovascular Prevention 2017. National Recommendations Russ J Cardiol. 2018;23(6):7-122 (In Russ.) DOI:10.15829/1560-4071-2018-6-7-122.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli M., Hoes A., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37:235-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation><mixed-citation xml:lang="en">Piepoli M., Hoes A., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37:235-81. DOI:10.1093/eurheartj/ehw106.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Damen J.A., Pajouheshnia R., Heus P., et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis. BMC Medicine. 2019;17(1):109. DOI:10.1186/s12916-019-1340-7.</mixed-citation><mixed-citation xml:lang="en">Damen J.A., Pajouheshnia R., Heus P., et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis. BMC Medicine. 2019;17(1):109. DOI:10.1186/s12916-019-1340-7.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis J., Bethishou L., Tsu L.V. Aspirin Use for Primary Prevention of Cardiovascular Disease in Older Patients: A Review of Clinical Guidelines and Updated Evidence. Sr Care Pharm. 2019;34(9):580-94. DOI:10.4140/TCP.n.2019.580.</mixed-citation><mixed-citation xml:lang="en">Lewis J., Bethishou L., Tsu L.V. Aspirin Use for Primary Prevention of Cardiovascular Disease in Older Patients: A Review of Clinical Guidelines and Updated Evidence. Sr Care Pharm. 2019;34(9):580-94. DOI:10.4140/TCP.n.2019.580.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">De Berardis G., Sacco M., Strippoli G.F., et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009;339:b4531. DOI:10.1136/bmj.b4531.</mixed-citation><mixed-citation xml:lang="en">De Berardis G., Sacco M., Strippoli G.F., et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009;339:b4531. DOI:10.1136/bmj.b4531.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F., Baigent C., Catapano A.L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. DOI:10.1093/eurheartj/ehz455.</mixed-citation><mixed-citation xml:lang="en">Mach F., Baigent C., Catapano A.L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. DOI:10.1093/eurheartj/ehz455.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sabatine M.S., Giugliano R.P., Keech A.C., et al.; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713-22. DOI:10.1056/NEJMoa1615664.</mixed-citation><mixed-citation xml:lang="en">Sabatine M.S., Giugliano R.P., Keech A.C., et al.; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713-22. DOI:10.1056/NEJMoa1615664.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz G.G., Steg P.G., Szarek M., et al.; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097-107. DOI:10.1056/NEJMoa1801174.</mixed-citation><mixed-citation xml:lang="en">Schwartz G.G., Steg P.G., Szarek M., et al.; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097-107. DOI:10.1056/NEJMoa1801174.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Научно-организационный комитет проекта ЭССЕ-РФ. Эпидемиология сердечно-сосудистых заболеваний в различных регионах России (ЭССЕ-РФ). Обоснование и дизайн исследования. Профилактическая Медицина. 2013;6:25-34.</mixed-citation><mixed-citation xml:lang="en">Research organizing committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study J. Profilakticheskaya Meditsina. 2013;6:5-34 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T.W., Asman K., Gentzke A.S., et al. Tobacco product use among adults—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(44):1225-32. DOI:10.15585/mmwr.mm6744a2.</mixed-citation><mixed-citation xml:lang="en">Wang T.W., Asman K., Gentzke A.S., et al. Tobacco product use among adults—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(44):1225-32. DOI:10.15585/mmwr.mm6744a2.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Филиппов Е.В., Якушин С.С., Петров В.С. Дислипидемии и их ассоциации с хроническими неинфекционными заболеваниями (исследование МЕРИДИАН-РО). Клиницист. 2016;10(3):32-40.</mixed-citation><mixed-citation xml:lang="en">Filippov E.V., Yakushin S.S., Petrov V.S. Dyslipidemia and its relationship with chronic non-communicable diseases (according to the MERIDIAN-RO study). Clinician. 2016;10(3):32-40 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Долгалев И.В., Бразовская Н.Г., Иванова А.Ю., и др. Влияние артериальной гипертензии, курения и их сочетания на смертность (по результатам 27-летнего когортного проспективного исследования неорганизованной популяции г. Томска). Российский Кардиологический Журнал. 2019;(1):32-7. DOI:10.15829/1560-4071-2019-1-32-37</mixed-citation><mixed-citation xml:lang="en">Dolgalev I.V., Brazovskaya N.G., Ivanova A.Y., et al. Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk). Russian Journal of Cardiology. 2019;(1):32-7 (In Russ.) DOI:10.15829/1560-4071-2019-1-32-37</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatnagar A. Cardiovascular Perspective of the Promises and Perils of E-Cigarettes. Circ Res. 2016;118(12):1872-5. DOI:10.1161/CIRCRESAHA.116.308723.</mixed-citation><mixed-citation xml:lang="en">Bhatnagar A. Cardiovascular Perspective of the Promises and Perils of E-Cigarettes. Circ Res. 2016;118(12):1872-5. DOI:10.1161/CIRCRESAHA.116.308723.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lippi G., Favaloro E.J., Meschi T., et al. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost. 2014;40:60-5. DOI:10.1055/s-0033-1363468.</mixed-citation><mixed-citation xml:lang="en">Lippi G., Favaloro E.J., Meschi T., et al. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost. 2014;40:60-5. DOI:10.1055/s-0033-1363468.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Moheimani R.S., Bhetraratana M., Yin F., et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278- 84. DOI:10.1001/jamacardio.2016.5303.</mixed-citation><mixed-citation xml:lang="en">Moheimani R.S., Bhetraratana M., Yin F., et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278- 84. DOI:10.1001/jamacardio.2016.5303.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Гамбарян М.Г. Вся правда об электронных сигаретах: российская реальность. Часть I. Электронные сигареты — угроза для людей и антитабачной политики в России. Актуальность правового регулирования. Профилактическая Медицина. 2019;22(5):7-15. DOI:10.17116/profmed2019220517.</mixed-citation><mixed-citation xml:lang="en">Gambaryan M.G. The whole truth of electronic cigarettes: the Russian reality. Part I. Electronic cigarettes a threat to people and Tobacco control policy in Russia. Urgency for legal regulation. Preventive Medicine. 2019;22(5):7-15 (In Russ.) DOI:10.17116/profmed2019220517.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А. Структура факторов сердечно-сосудистого риска и качество мер их профилактики в первичном звене здравоохранения в России и в Европейских странах (по результатам исследования EURIKA). Кардиоваскулярная Терапия и Профилактика. 2012;11(1):11-6.</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A. Prevalence of cardiovascular risk factors and cardiovascular prevention quality in primary healthcare in Russia and European countries: EURIKA Study results. Cardiovascular Therapy and Prevention. 2012;11(1):11-6 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Ерина А.М., Ротарь О.П., Орлов А.В., и др. Предгипертензия и кардиометаболические факторы риска (по материалам исследования ЭССЕ-РФ). Артериальная Гипертензия. 2017;23(3):243-52. DOI:10.18705/1607-419X2017-23-3-243-252.</mixed-citation><mixed-citation xml:lang="en">Erina A.M., Rotar O.P., Orlov A.V., et al. Prehypertension and cardiometabolic risk factors (data of the ESSE-RF study) Arterial Hypertension. 2017;23(3):243-52 (In Russ.) DOI:10.18705/1607-419X2017-23-3-243-252.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Кривошапова К.Е., Цуганкова Д.П., Бардараш О.Л. Низкая физическая активность как фактор сердечно-сосудистой и общей смертности. Системная Гипертензия. 2018;15(3):14-20. DOI:10.26442/2075-082X_2018.3.14-20.</mixed-citation><mixed-citation xml:lang="en">Krivoshapova K.E., Tsygankova D.P., Barbarash O.L. Physical inactivity as a risk factor for cardiovascular morbidity and mortality. Systemic Hypertension. 2018;15(3):14-20 (In Russ.) DOI:10.26442/2075-082X_2018.3.14-20.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Löllgen H., Böckenhoff A., Knapp G. Physical Activity and All-cause Mortality: An Updated Meta-analysis with Different Intensity Categories. International Journal of Sports Medicine. 2009;30(03):213-24. DOI:10.1055/s-0028-1128150.</mixed-citation><mixed-citation xml:lang="en">Löllgen H., Böckenhoff A., Knapp G. Physical Activity and All-cause Mortality: An Updated Meta-analysis with Different Intensity Categories. International Journal of Sports Medicine. 2009;30(03):213-24. DOI:10.1055/s-0028-1128150.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Вялова М.О., Шварц Ю.Г. Артериальная гипертензия и показатели кардиоваскулярного риска у лиц среднего и пожилого возраста, занимающихся спортом. Кардиология: Новости, Мнения, Обучение. 2019;7(2):36-44. DOI:10.24411/2309-1908-2019-12004.</mixed-citation><mixed-citation xml:lang="en">Vyalova M.O., Shvarts Yu.G. Arterial hypertension and cardiovascular risk score in people in their middle and late adulthood during sports and physical training. Kardiologiya: Novosti, Mneniya, Obuchenie. 2019;7(2):36-44 (In Russ.) DOI:10.24411/2309-1908-2019-12004.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Гогигава С.Е., Румба О.Г. Сочетание нагрузок аэробного и анаэробного характеров на занятиях по физической культуре в ВУЗе. Ученые Записки Университета Имени П.Ф. Лесгафта. 2013;7(101):38-43. DOI:10.5930/issn.1994-4683.2013.07.101.p38-43.</mixed-citation><mixed-citation xml:lang="en">Goginava S.E., Rumba O.G. Combination of the loads of aerobic and anaerobic characters during the physical culture classes in higher education. Scientific-theoretical journal Uchenye zapiski universiteta imeni P.F. Lesgafta. 2013;7(101):38-43 (In Russ.) DOI:10.5930/issn.1994-4683.2013.07.101.p38-43.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Аметов А.С., Пашкова Е.Ю, Шарафетдинов А.С., Жигарева А.В. Роль и место ингибиторов натрий-глюкозного котранспортера-2 в многофакторном влиянии на сахарный диабет 2 типа. Эндокринология: Новости, Мнения, Общение. 2019;8(1):8-16. DOI:10.24411/2304-9529-2019-11001.</mixed-citation><mixed-citation xml:lang="en">Ametov A.S., Pashkova E.Yu., Sharafetdinov A.S., Zhigareva A.V. The role and place of sodium-glucose cotransporter-2 inhibitors in multifactorial management of type 2 diabetes mellitus. Endokrinologiya: Novosti, Mneniya, Obuchenie. 2019;8(1):8-16 (In Russ.) DOI:10.24411/2304-9529-2019-11001.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Meier J.J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology. 2012;8(12):728-42. DOI:10.1038/nrendo.2012.140.</mixed-citation><mixed-citation xml:lang="en">Meier J.J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology. 2012;8(12):728-42. DOI:10.1038/nrendo.2012.140.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Billioux A., Verlander K., Anthony S., Alley D. Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool. NAM Perspectives. Discussion Paper. Washington, DC: National Academy of Medicine; 2017. DOI:10.31478/201705b.</mixed-citation><mixed-citation xml:lang="en">Billioux A., Verlander K., Anthony S., Alley D. Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool. NAM Perspectives. Discussion Paper. Washington, DC: National Academy of Medicine; 2017. DOI:10.31478/201705b.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
